
PETS
Petmed Express Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.640
Open
2.520
VWAP
2.60
Vol
249.12K
Mkt Cap
54.22M
Low
2.490
Amount
648.34K
EV/EBITDA(TTM)
-0.06
Total Shares
20.61M
EV
-490.86K
EV/OCF(TTM)
-0.10
P/S(TTM)
0.24
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q2
FY2026Q1
60.76M
+2%
-0.060
+100%
69.31M
+2%
0.040
-63.64%
51.10M
-23.16%
-0.070
-138.89%
Estimates Revision
The market is revising Downward the revenue expectations for PetMed Express, Inc. (PETS) for FY2026, with the revenue forecasts being adjusted by -7.93% over the past three months. During the same period, the stock price has changed by -15.69%.
Revenue Estimates for FY2026
Revise Downward

-7.93%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward

+83.33%
In Past 3 Month
Stock Price
Go Down

-15.69%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Petmed Express Inc (PETS.O) is -11.73, compared to its 5-year average forward P/E of -8.08. For a more detailed relative valuation and DCF analysis to assess Petmed Express Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-8.08
Current PE
-11.73
Overvalued PE
99.64
Undervalued PE
-115.80
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
10.89
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.99
Undervalued EV/EBITDA
5.78
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued
5Y Average PS
1.14
Current PS
2.58
Overvalued PS
1.87
Undervalued PS
0.41
Financials
Annual
Quarterly
FY2025Q4
YoY :
-21.95%
46.47M
Total Revenue
FY2025Q4
YoY :
+25.68%
-4.82M
Operating Profit
FY2025Q4
YoY :
+132.14%
-11.64M
Net Income after Tax
FY2025Q4
YoY :
+124.00%
-0.56
EPS - Diluted
FY2025Q4
YoY :
-21.28%
4.62M
Free Cash Flow
FY2025Q4
YoY :
-3.51%
36.31
Gross Profit Margin - %
FY2025Q4
-0.17
FCF Margin - %
FY2025Q4
YoY :
+197.27%
-25.06
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 174.01% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
200.1K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
7
954.9K
USD
Months
6-9
4
945.2K
USD
Months
0-12
9
990.0K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 174.01% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
200.1K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
7
954.9K
USD
Months
6-9
4
945.2K
USD
Months
0-12
9
990.0K
USD
Months
PETS News & Events
Events Timeline
2025-10-20 (ET)
2025-10-20
08:41:51
James LaCamp Joins PetMed Express Board of Directors
2025-08-12 (ET)
2025-08-12
16:50:50
PetMed Express CEO Sandra Campos, CFO Robyn D'Elia resign
2025-07-03 (ET)
2025-07-03
08:36:43
PetMed Express receives non-compliance notice from Nasdaq
Sign Up For More Events
Sign Up For More Events
News
7.0
11-01GlobenewswirePETMED EXPRESS UPDATE: Bragar Eagel & Squire, P.C. Alerts PetMed Express Investors About Ongoing Investigation for Stockholders
7.0
10-15GlobenewswirePETMED ALERT: Bragar Eagel & Squire, P.C. Notifies PetMed Express Investors About Ongoing Investigation for Stockholders
7.0
10-09GlobenewswirePetMed Express (PETS) Under Investor Examination Due to Filing Delays, Executive Exits, and Acknowledged Accounting Rule Breaches -- Hagens Berman
Sign Up For More News
People Also Watch

FCAP
First Capital Inc
44.100
USD
-0.59%

SND
Smart Sand Inc
2.090
USD
-1.88%

SOL
Emeren Group Ltd
1.890
USD
0.00%

ATOS
Atossa Therapeutics Inc
0.821
USD
+0.74%

MASS
908 Devices Inc
7.380
USD
-5.38%

UPLD
Upland Software Inc
1.720
USD
-6.52%

VRA
Vera Bradley Inc
2.350
USD
0.00%

ECOR
electroCore, Inc.
5.830
USD
-0.17%

BRAG
Bragg Gaming Group Inc
2.070
USD
-0.48%
FAQ
What is Petmed Express Inc (PETS) stock price today?
The current price of PETS is 2.58 USD — it has increased 5.31 % in the last trading day.





